Everest Hill Group Inc.

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
28
Insider Sells Sum
$91.89M

Insider Activity of Everest Hill Group Inc.

The largest sale of all time was on 2023-02-06 and amounted to 540000 shares of AdaptHealth Corp. for $11.21M.

Biography of Everest Hill Group Inc.

No biography is available at this moment.

2023-02-06SaleAdaptHealth Corp.
AHCO
540,000
0.4146%
$20.75$11.21M-47%
2023-02-01SaleAdaptHealth Corp.
AHCO
44,789
0.0328%
$21.00$940,569-49.23%
2023-01-31SaleAdaptHealth Corp.
AHCO
55,211
0.0403%
$21.00$1.16M-48.97%
2023-01-18SaleAdaptHealth Corp.
AHCO
director
4,789
0.0037%
$22.00$105,358-47.88%
2023-01-13SaleAdaptHealth Corp.
AHCO
director
10,201
0.0074%
$21.00$214,221-47.97%
2023-01-12SaleAdaptHealth Corp.
AHCO
director
340,000
0.2418%
$20.00$6.8M-46.02%
2023-01-10SaleAdaptHealth Corp.
AHCO
director
200,000
0.1449%
$20.00$4M-44.75%
2022-11-11SaleAdaptHealth Corp.
AHCO
director
23,583
0.0177%
$23.00$542,409-46.34%
2022-11-02SaleAdaptHealth Corp.
AHCO
director
5,859
0.0045%
$23.00$134,757-42.17%
2022-11-01SaleAdaptHealth Corp.
AHCO
director
45,999
0.0344%
$23.00$1.06M-44.03%
2022-10-28SaleAdaptHealth Corp.
AHCO
director
10,437
0.0078%
$23.00$240,051-42.5%
2022-10-26SaleAdaptHealth Corp.
AHCO
director
165,968
0.1183%
$22.00$3.65M-42.24%
2022-10-25SaleAdaptHealth Corp.
AHCO
director
114,032
0.0832%
$22.00$2.51M-40.73%
2022-10-24SaleAdaptHealth Corp.
AHCO
director
14,605
0.0111%
$22.00$321,310-37.81%
2022-10-18SaleAdaptHealth Corp.
AHCO
director
5,395
0.0041%
$22.00$118,690-36.64%
2022-10-17SaleAdaptHealth Corp.
AHCO
director
100,000
0.074%
$21.00$2.1M-36.03%
2022-10-13SaleAdaptHealth Corp.
AHCO
director
110,602
0.0827%
$22.01$2.43M-38.15%
2022-09-23SaleAdaptHealth Corp.
AHCO
10 percent owner
200,000
0.1481%
$19.10$3.82M-27.94%
2022-09-19SaleAdaptHealth Corp.
AHCO
10 percent owner
100,000
0.0724%
$21.50$2.15M-36.78%
2022-09-16SaleAdaptHealth Corp.
AHCO
10 percent owner
200,000
0.1479%
$20.00$4M-30.22%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.